SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions
16 references·2 citing·42 second hop
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions (2017)Developing a Value Framework: The Need to…Estimating a cost‐effectiveness threshold for the Spanish NHS (2017)Estimating a cost‐effectivene…Measuring and Valuing Health Benefits for Economic Evaluation (2016)Measuring and Valuing Health …Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Country-Level Cost-Effectiven…Cost-Effectiveness in Health and Medicine (2016)Cost-Effectiveness in Health …Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Methods for the estimation of…Measuring the Value of Prescription Drugs (2015)Measuring the Value of Prescr…Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey (2014)Use of generic and condition-…The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature (2014)The Willingness to Pay for a …CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? (2014)CAUSES FOR CONCERN: IS NICE F…Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA) (2011)Bridging Health Technology As…Measuring and Valuing Health Benefits for Economic Evaluation (2007)Measuring and Valuing Health …Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…On the economic foundations of CEA. Ladies and gentlemen, take your positions! (2000)On the economic foundations o…Net Health Benefits (1998)Net Health BenefitsHealth Status and Health Policy: Allocating Resources to Health Care (1994)Health Status and Health Poli…Measurement of health state utilities for economic appraisal (1986)Measurement of health state u…Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis (2024)Population-health impact of n…Estimating the Marginal Productivity of the English National Health Service From 2003 to 2012 (2019)Estimating the Marginal Produ…Social Choice and Individual Values. (1951)Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life (1989)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)Conducting Discrete Choice Experiments to Inform Healthcare Decision Making (2008)Theory of games and economic behavior (2019)The PHQ-9 (2001)A Brief Measure for Assessing Generalized Anxiety Disorder (2006)Cost–effectiveness thresholds: pros and cons (2016)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)Modeling Valuations for EuroQol Health States (1997)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures (2014)Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report (2017)Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report (2019)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion (2020)Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures (2023)A Single Index of Mortality and Morbidity (1971)¿Qué es una tecnología sanitaria eficiente en España? (2002)Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System (2017)Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers (2019)Increasing risk II: Its economic consequences (1971)The Analytics of Uncertainty and Information (1992)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures (2009)Development of a self-report measure of capability wellbeing for adults: the ICECAP-A (2011)Validity and Reliability of the Assessment of Quality of Life (AQoL)-8D Multi-Attribute Utility Instrument (2013)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)Simulating the Potential Impacts of COVID-19 School Closures on Schooling and Learning Outcomes: A Set of Global Estimates (2020)Developing a descriptive system for a new preference-based measure of health-related quality of life for children (2009)Populating an Economic Model with Health State Utility Values: Moving toward Better Practice (2010)Outcomes of social care for adults: developing a preference-weighted measure. (2012)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1986Measurement of health state utilities for economic appraisal2,204 cited
  • 2016Cost-Effectiveness in Health and Medicine1,550 cited
  • 1998Net Health Benefits1,104 cited
  • 2016Measuring and Valuing Health Benefits for Economic Evaluation1,052 cited
  • 2016Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research889 cited
  • 2015Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold857 cited
  • 2007Measuring and Valuing Health Benefits for Economic Evaluation439 cited
  • 2014Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey418 cited
  • 2017Estimating a cost‐effectiveness threshold for the Spanish NHS297 cited
  • 2014The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature261 cited
  • 1994Health Status and Health Policy: Allocating Resources to Health Care261 cited
  • 2011Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA)169 cited
  • 2000On the economic foundations of CEA. Ladies and gentlemen, take your positions!

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

148 cited
  • 2015Measuring the Value of Prescription Drugs144 cited
  • 2014CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS?114 cited
  • Cited by

    • 2024Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis85 cited
    • 2019Estimating the Marginal Productivity of the English National Health Service From 2003 to 201281 cited